NYSE · Medical - Care Facilities

Solventum Corporation (SOLV) Stock

$85.41 -2.33% NYSE: SOLV Healthcare

Valuation

MetricValue
Price$85.41
Market Cap$14.54B
P/E Ratio10.69
P/B Ratio3.18
P/S Ratio1.83
EPS (TTM)$8.88
52-Week High$94.16
52-Week Low$62.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE28.96%
ROA10.07%
ROCE19.63%
Gross Margin26.20%
Operating Margin26.20%
Net Margin17.26%
Debt/Equity1.10
Current Ratio1.23

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.2B$8.1B$8.2B$8.3B$8.3B
Operating Profit$1.9B$1.7B$1.7B$1.0B$2.2B
Net Profit$1.5B$1.3B$1.3B$479.0M$1.6B
EPS$8.47$7.79$7.79$2.76$8.88
Op Margin23.0%20.8%20.6%12.6%26.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.1B$13.6B$13.9B$14.5B$14.3B
Total Liabilities$2.0B$1.9B$2.3B$11.5B$9.2B
Cash$91.0M$61.0M$194.0M$762.0M$878.0M
Borrowings$112.0M$95.0M$8.3B$8.0B$5.0B

Latest News

2 S&P 500 Stocks to Own for Decades and 1 We Question StockStory · Jul 7, 2026 3 Mid-Cap Stocks We Steer Clear Of StockStory · Jun 29, 2026 3 Healthcare Stocks with Questionable Fundamentals StockStory · Jun 25, 2026 Solventum Stock: Is SOLV Underperforming the Healthcare Sector? Barchart · Jun 22, 2026 Cooper Companies Stock: Is COO Underperforming the Healthcare Sector? Barchart · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.2B$1.7B$1.9B$1.2B$369.0M
Investing Cash Flow$-555.0M$-504.0M$-520.0M$-760.0M$2.4B
Financing Cash Flow$-2.0B$-1.5B$-1.6B$-8.2B$13.0M
Net Cash Flow$-33.0M$-30.0M$133.0M$568.0M$116.0M
Free Cash Flow$1.9B$1.4B$1.6B$805.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA7.74
FCF Yield-0.78%
Quick Ratio0.74
Interest Coverage7.81
Return 1Y20.11%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BAXBaxter International Inc. $25.30 -1.36% -11.46 $13.08B 0.17%
BDXBecton, Dickinson and Company $198.91 -0.75% 55.37 $54.18B 2.28%
CNVVFConvaTec Group Plc $2.95 +4.61% 32.81 $5.75B 3.73%
COOThe Cooper Companies, Inc. $61.21 -0.71% 19.29 $11.64B 0.00%
HSICHenry Schein, Inc. $84.96 -1.21% 24.53 $9.47B 0.00%

About Solventum Corporation

Solventum Corporation is led by CEO Bryan C. Hanson, employs 20,000 people, headquartered in Maplewood, US, publicly traded since 2024.

Solventum Corporation (SOLV) stock trades at $85.41 with a market capitalization of $14.54B. The stock is valued at a price-to-earnings (P/E) ratio of 10.69, price-to-book of 3.18, price-to-sales of 1.83. Over the past 52 weeks the stock has ranged between $62.38 and $94.16, and currently trades 9.3% below its 52-week high.

On profitability, Solventum Corporation generates a return on equity (ROE) of 28.96%, above the typical market range of roughly 12-15%, return on capital employed of 19.63%, an operating margin of 26.20%, a net profit margin of 17.26%.

Solventum Corporation by the numbers, 2020–2025

Between 2020 and 2025 Solventum Corporation reported revenue of $7.3B rising to $8.3B, a change of +14.3% across 6 years. Compounded, revenue has grown 2.7% a year over five years, 0.8% over three, 0.9% over the last twelve months. Net profit rose to $1.6B.

Operating margin went from 19.6% in 2020 to 26.2% in 2025, a gain of 6.6 percentage points. The most recent net margin is 17.26%. On a trailing twelve-month basis to Jun '26, revenue is $8.3B and net profit $1.4B.

Borrowings stand at $5.0B, cash from operations was $369.0M in the latest year, positive in 6 of the last 6.

Return on equity has averaged 16.4% over five years, and was 30.8% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Solventum Corporation (SOLV) — frequently asked questions

What is Solventum Corporation (SOLV) stock price today?

Solventum Corporation (SOLV) is currently trading at $85.41, down 2.33% today.

What is SOLV P/E ratio?

Solventum Corporation's P/E ratio is 10.69. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.

What is SOLV return on equity (ROE)?

Solventum Corporation's return on equity (ROE) is 28.96%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is Solventum Corporation's market cap?

Solventum Corporation has a market capitalization of $14.54B.

Does SOLV pay a dividend?

Solventum Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does SOLV carry?

Solventum Corporation has a debt-to-equity ratio of 1.10. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is SOLV's profit margin?

Solventum Corporation reports a net profit margin of 17.26% — the share of revenue left after every cost, including tax and interest.

What sector is SOLV in?

Solventum Corporation is classified under Healthcare, in the Medical - Care Facilities industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is SOLV listed on?

Solventum Corporation trades on NYSE under the ticker SOLV.

What is SOLV's 52-week range?

Over the last year Solventum Corporation has traded between $62.38 and $94.16.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens SOLV currently matches

On the figures above, Solventum Corporation passes the filters for 17 of our ready-made screens, among them Low PE Stocks, Undervalued Large Cap Stocks, High ROE Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low PE StocksUndervalued Large Cap StocksHigh ROE StocksHigh ROA StocksLarge Cap StocksStocks With Insider BuyingHealthcare Stocks To BuyStock Screener StarterFree Stock Screener PicksStocks With PE Under 20Low PE High EPS StocksStocks Under $100Low PE High ROE StocksNYSE Listed StocksStocks With PE Under 25Stocks With PE Under 30High ROE Stocks Under $100

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.